EdithZemanickMD

PubMed

• Remote endpoints for clinical trials in cystic fibrosis: Report from the U.S. CF foundation remote endpoints task force.
  Jordana E Hoppe, Jacquelyn Sjoberg, Gina Hong, Katie Poch, Edith T Zemanick, Stephanie Thee, Claire Edmondson, Dhiren Patel, Meghana Sathe, Drucy Borowitz, Melissa S P...> ;Journal of Cystic Fibrosis. 2024 Feb 29
• Integrating airway microbiome and blood proteomics data to identify multi-omic networks associated with response to pulmonary infection.
  Graham, B., Harris, J., Wagner, B., Zemanick, E.> ;The Microbe. 2023 Dec 1
• Olfactory loss in people with cystic fibrosis: Community perceptions and impact.
  Jessa E Miller, Christine M Liu, Edith T Zemanick, Jason C Woods, Christopher H Goss, Jennifer L Taylor-Cousar, Daniel M Beswick> ;Journal of Cystic Fibrosis. 2023 Nov 17
• Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection.
  Brandie D Wagner, Edith T Zemanick, Scott D Sagel, Charles E Robertson, Mark J Stevens, Nicole Mayer-Hamblett, George Retsch-Bogart, Bonnie W Ramsey, J Kirk Harris> ;BMC Microbiology. 2023 Oct 27
• 8 citations
  Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.
  Nicole Mayer-Hamblett, John Paul Clancy, Raksha Jain, Scott H Donaldson, Isabelle Fajac, Christopher H Goss, Deepika Polineni, Felix Ratjen, Bradley S Quon, Edith T Ze...> ;The Lancet. Respiratory Medicine. 2023 Oct 1
• 1 citations
  A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment Strategies.
  Don B Sanders, Traci M Bartz, Edith T Zemanick, Jordana E Hoppe, Karen D Hinckley Stukovsky, Jonathan D Cogen, Lisa Bendy, Sharon McNamara, Erika Enright, Noah A Kime,...> ;Annals of the American Thoracic Society. 2023 Dec 1
• Infection, Allergy, and Inflammation: The Role ofin Cystic Fibrosis.
  T Spencer Poore, Edith T Zemanick> ;Microorganisms. 2023 Aug 5
• Upper airway microbiota development in infants with cystic fibrosis diagnosed by newborn screen.
  J Kirk Harris, Brandie D Wagner, Charles E Robertson, Mark J Stevens, Conor Lingard, Drucy Borowitz, Daniel H Leung, Sonya L Heltshe, Bonnie W Ramsey, Edith T Zemanick> ;Journal of Cystic Fibrosis. 2023 Jul 1
• 1 citations
  Complications and Practice Variation in the Use of Peripherally Inserted Central Venous Catheters in People With Cystic Fibrosis: The Prospective Study of Peripherally...
  Alex H Gifford, Alexandra C Hinton, Shijing Jia, Samya Z Nasr, Joel D Mermis, Thomas Lahiri, Edith T Zemanick, Charlotte C Teneback, Patrick A Flume, Emily A DiMango, ...> ;Chest. 2023 Sep 1
• 6 citations
  Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy.
  Kamyron D Jordan, Edith T Zemanick, Jennifer L Taylor-Cousar, Jordana E Hoppe> ;Expert Review of Respiratory Medicine. 2023 Feb 1
• 1 citations
  Therapeutic beta-lactam dosages and broad-spectrum antibiotics are associated with reductions in microbial richness and diversity in persons with cystic fibrosis.
  Andrea Hahn, Aszia Burrell, Hollis Chaney, Iman Sami, Anastassios C Koumbourlis, Robert J Freishtat, Keith A Crandall, Edith T Zemanick> ;Scientific Reports. 2023 Jan 21
• Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing.
  Jordana E Hoppe, Edith T Zemanick, Stacey L Martiniano> ;American Journal of Respiratory and Critical Care Medicine. 2022 Dec 1
• 2 citations
  Impact of Antibiotics on the Lung Microbiome and Lung Function in Children With Cystic Fibrosis 1 Year After Hospitalization for an Initial Pulmonary Exacerbation.
  Zaina Inam, Erin Felton, Aszia Burrell, Hollis Chaney, Iman Sami, Anastassios C Koumbourlis, Robert J Freishtat, Edith T Zemanick, Keith A Crandall, Andrea Hahn> ;Open Forum Infectious Diseases. 2022 Sep 1
• Application of gap time analysis with flexible hazards to pulmonary exacerbations in the EPIC observational study.
  John D Rice, Rachel L Johnson, Elizabeth Juarez-Colunga, Edith T Zemanick, Margaret Rosenfeld, Brandie D Wagner> ;Biometrical Journal. Biometrische Zeitschrift. 2022 Aug 1
• 2 citations
  Using metabolic potential within the airway microbiome as predictors of clinical state in persons with cystic fibrosis.
  Gabriella Shumyatsky, Aszia Burrell, Hollis Chaney, Iman Sami, Anastassios C Koumbourlis, Robert J Freishtat, Keith A Crandall, Edith T Zemanick, Andrea Hahn> ;Frontiers in Medicine. 2022 Jan 1
• 6 citations
  Clinical characteristics of people with cystic fibrosis and frequent fungal infection.
  T Spencer Poore, Maxene Meier, Elinor Towler, Stacey L. Martiniano, John T. Brinton, Emily M. DeBoer, Scott D. Sagel, Brandie D. Wagner, Edith T. Zemanick> ;Pediatric Pulmonology. 2021 Oct 23
• 3 citations
  Impact of Anaerobic Antibacterial Spectrum on Cystic Fibrosis Airway Microbiome Diversity and Pulmonary Function.
  Michael J. Bozzella, Hollis Chaney, Iman Sami, Anastassios C. Koumbourlis, James E. Bost, Edith T. Zemanick, Robert J. Freishtat, Keith A. Crandall, Andrea Hahn> ;The Pediatric Infectious Disease Journal. 2021 Jul 15
• 22 citations
  Cardiovascular complications in cystic fibrosis: A review of the literature.
  T. Spencer Poore, Jennifer L. Taylor-Cousar, Edith T. Zemanick> ;Journal of Cystic Fibrosis. 2021 Jun 14
• 5 citations
  Importance of beta-lactam pharmacokinetics and pharmacodynamics on the recovery of microbial diversity in the airway of persons with cystic fibrosis
  Andrea Hahn, Aszia Burrell, Hollis Chaney, Iman Sami, Anastassios C. Koumbourlis, Robert J. Freishtat, Edith T. Zemanick, Stan G. Louie, Keith A. Crandall> ;Journal of Investigative Medicine. 2021 May 21
• 4 citations
  Fungal Infection and Inflammation in Cystic Fibrosis.
  T. Spencer Poore, Gina Hong, Edith T. Zemanick> ;Pathogens. 2021 May 18
• 12 citations
  Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis.
  Patricia M Lenhart-Pendergrass, M. Anthony, Sabina Sariyska, Ashley Andrews, Heather Scavezze, Elinor Towler, Stacey L. Martiniano, Jordana E. Hoppe, Edith T. Zemanick> ;Pediatric Pulmonology. 2021 Apr 13
• 115 citations
  A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.
  Edith T. Zemanick, Jennifer L. Taylor-Cousar, Jane Davies, Ronald L. Gibson, Marcus A. Mall, Edward F. McKone, Paul McNally, Bonnie W. Ramsey, Jonathan H. Rayment, Ste...> ;American Journal of Respiratory and Critical Care Medicine. 2021 Jun 25
• Change in circulating proteins during treatment of pulmonary exacerbation in patients with cystic fibrosis.
  Brandie D. Wagner, Asem Berkalieva, Monica Borges, Grant Fleming, Noah Graham, Emily Peterson, Xin Jin, Edith T. Zemanick> ;Health Science Reports. 2021 Mar 1
• 23 citations
  Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...
  Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain, Rainald Fischer, Kris De Boeck, Gregory S Sawicki, Philip Chang, Hildegarde Paz-Dia...> ;The Lancet. Respiratory Medicine. 2021 Feb 10
• 11 citations
  Measuring the impact of CFTR modulation on sweat chloride in cystic fibrosis: Rationale and design of the CHEC-SC study.
  Edith T. Zemanick, Michael W. Konstan, Donald R. VanDevanter, Steven M. Rowe, John P. Clancy, Katherine Odem-Davis, M. Skalland, Nicole Mayer-Hamblett> ;Journal of Cystic Fibrosis. 2021 Feb 8
• Join now to see all

Journal Articles

• Changes in Microbiome Diversity Following Beta-Lactam Antibiotic Treatment Are Associated with Therapeutic Versus Subtherapeutic Antibiotic Exposure in Cystic Fibrosis  
  Geovanny F Perez, Anastassios C Koumbourlis, Andrea Hahn, Robert J Freishtat, Edith T Zemanick, Hollis Chaney, Nature
• Novel Application of Aptamer Proteomic Analysis in Cystic Fibrosis Bronchoalveolar Lavage Fluid  
  Scott D Sagel, Robin R Deterding, Emily M DeBoer, Jonathan Popler, Edith T Zemanick, Frank J Accurso, PROTEOMICS – Clinical Applications
• Volatile Molecules from Bronchoalveolar Lavage Fluid Can ‘Rule-In’ Pseudomonas Aeruginosa and ‘Rule-Out’ Staphylococcus Aureus Infections in Cystic Fibrosis Patients  
  Christiaan A Rees, Edith T Zemanick, Nature